Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European … – Nasdaq
Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European …
Nasdaq “Data from this ongoing BP-004 study in Europe, along with comparative data from an observational trial of pediatric patients undergoing a stem cell transplant from matched unrelated donors, are expected to support the filing of a European Marketing … |